Merck will assess Quris' AI 'patient-on-a-chip' drug safety ...

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic can

2nd Gene Therapy Immunogenicity

The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy c

Elsevier gets FDA backing for ‘predictive toxicology’ projec...

New Speakers from Roche & Imperial College announced for...

SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.

Speaker Interview with Pau Aceves Released - SMi’s ADMET Eve...

The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of bioph

SMi’s 13th Annual ADMET conference 2018 brochure released

The annual ADMET conference is returning to London, UK for its 13th year running and will be taking place at the Holiday Inn Kensington Forum on the 9th and 10